île de France; Hauts-de-Seine;
Location of affected unit(s)
Throughout France - Mainly in Ile de France
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

330 jobs
Number of planned job losses
Job loss
35 jobs
Number of planned job creations
Job creation
Announcement Date
12 September 2008
Employment effect (start)
12 September 2008
Foreseen end date
31 December 2008


Schering-Plough, a French subsidiary of the pharmaceutical company Schering-Plough Corporation announced a restructuring plan affecting 330 jobs in France with the direct dismissals of 206 employees through voluntary redundancy measures by the end of the year.

The restructuring which follows the acquisition of the Dutch group Organon SA mainly concerns sales staff across the territory and the employees of the two Headquarters in Levallois and Puteaux, in Ile de France. 35 new jobs will also be created.

Schering-Plough employs 50.000 people around the world and the total workforce in France rises to approximately 1.900 employees as a result of the merger. In March 2009 the group underwent another merger with the pharmaceutical group Merck which could lead to further job losses world-wide.



Eurofound (2008), Schering-Plough, Merger/Acquisition in France, factsheet number 68781, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/68781.